2025-10-20 - Analysis Report
Okay, here's an analysis of Chevron Corp (CVX) based on the provided data.

## Chevron Corp (CVX) Analysis

**Company Overview:** Chevron Corp is an integrated energy company involved in the exploration, production, and transportation of crude oil and natural gas.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (CVX):** 36.54%
*   **Cumulative Return (VOO):** 97.05%
*   **Absolute Divergence:** -60.51% (CVX significantly underperformed VOO)
*   **Relative Divergence:** 4.1% (This suggests that Chevron's underperformance is near the lower end of its historical range compared to the S&P 500)

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
| :----------- | :------ | :------ | :------- | :----- | :------ |
| 2015-2017  | 33.0%   | 65.9%   | 5.0%     | 0.1    | 252.2  |
| 2016-2018  | 21.0%   | 71.9%   | 6.0%     | 0.2    | 219.2  |
| 2017-2019  | 3.0%    | 71.9%   | -19.0%    | 0.9    | 242.8  |
| 2018-2020  | -10.0%  | 79.6%   | -33.0%    | 0.7    | 170.2  |
| 2019-2021  | 22.0%   | 79.6%   | -25.0%    | 0.6    | 236.4  |
| 2020-2022  | 85.0%   | 83.2%   | 86.0%    | 0.3    | 361.6  |
| 2021-2023  | 49.0%   | 83.2%   | 47.0%    | 0.4    | 300.5  |
| 2022-2024  | -6.0%   | 83.2%   | -26.0%    | 0.2    | 291.8  |
| 2023-2025  | -46.0%  | 74.8%   | -107.0%   | 0.6    | 308.4  |

**Analysis:**

*   The data shows mixed performance of CVX relative to the market over different periods.
*   The Alpha values are quite volatile, indicating periods of both significant outperformance (e.g., 2020-2022) and significant underperformance (e.g., 2023-2025).
*   Beta values are generally low (below 1), suggesting that CVX is less volatile than the overall market (S&P 500). However, the beta has fluctuated, indicating periods of higher and lower correlation with the market.
*   The recent period (2023-2025) shows a very negative Alpha, indicating substantial underperformance, and a significant drop in CAGR.
*   MDD are significantly high

**2. Recent Price Action**

*   **Current Price:** 153.08
*   **Previous Close:** 151.71
*   **Change:** 0.9%
*   **5-day Moving Average:** 152.25
*   **20-day Moving Average:** 154.43
*   **60-day Moving Average:** 155.40

**Analysis:**

*   The stock price is currently below both its 20-day and 60-day moving averages, suggesting a short-term downtrend.
*   The recent 0.9% increase suggests a possible short-term bounce, but it needs to be confirmed by further price action.
*   The fact that price moved 0.9% compare to previouis close of 151.71 suggests that the price moved significantly
*   The price moving from 151.71 to 153.08 shows rapid increase

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment Recommended)
*   **RSI:** 44.81 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.12 (Slightly bearish, indicating that the short-term moving average is below the long-term moving average)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash
*   **Recent (20-day) Relative Divergence Change:** 0.3 (+, short-term increase)
*   **Expected Return:** 305.7% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests that, based on its risk model, investment in CVX is currently assessed as having medium risk.
*   The RSI is neutral, offering no strong buy or sell signal.
*   The PPO is slightly negative, suggesting a potential continuation of the downtrend, but it's not a strong signal.
*   The hybrid signal is to buy 100% of cash, indicating to buy
*   The recent increase in relative divergence is a positive sign, suggesting a potential short-term recovery in CVX's performance compared to the S&P 500.
*   The extremely high expected return should be treated with caution. It indicates that, if the model is accurate, a long-term, dollar-cost averaging investment strategy in CVX could significantly outperform the S&P 500. However, such a high return suggests that the model may be overestimating the potential.

**4. Recent News & Significant Events**

*   **[2025-10-18] U.S. Oil Growth Shifts from Shale to Gulf (Oilprice.com):** This could be a positive long-term trend for Chevron if it has significant Gulf operations.
*   **[2025-10-17] FERC approves commissioning extension for Plaquemines LNG plant (Offshore Technology):** This is unlikely to have a significant direct impact on Chevron.
*   **[2025-10-17] Warren Buffett plowed more than $1 billion into three stocks...gas (Fortune):**  Warren Buffet investing in gas can be seen as a bullish signal
*   **[2025-10-17] Raymond James Adjusts Price Target on Chevron to $160 From $170, Maintains Outperform Rating (MT Newswires):** A slight decrease in price target, but the "Outperform" rating is still positive.
*   **[2025-10-17] UBS Reaffirms Buy Rating on Chevron (CVX) Ahead of Q3 Earnings, Sees Long-Term Growth in Guyana and Beyond (Insider Monkey):**  This is a strong positive signal.
*   **[2025-10-16] Wall Street Analysts See Chevron (CVX) as a Buy: Should You Invest? (Zacks):**  General positive sentiment from analysts.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.15)
*   **Target Price:** Avg: 170.15 / High: 197.00 / Low: 124.00

**Analysis:**

*   Analyst consensus is generally positive on Chevron, with a "Buy" recommendation and a mean rating of 2.15.
*   The average target price of $170.15 suggests a potential upside from the current price.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
| :--------- | :---- | :--------- |
| 2025-08-07 | 1.45  | 44.38 B$   |
| 2025-05-08 | 2.01  | 46.10 B$   |
| 2024-11-07 | 2.49  | 48.93 B$   |
| 2024-08-07 | 2.43  | 49.57 B$   |
| 2025-08-07 | 2.43  | 49.57 B$   |

**Analysis:**

*   Recent earnings (EPS) and revenue have shown a downward trend. The latest EPS is significantly lower than previous quarters, and revenue has also decreased. This is a concerning sign.

**6. Financial Information**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-06-30 | $44.38B  | 29.69%        |
| 2025-03-31 | $46.10B  | 29.00%        |
| 2024-12-31 | $48.33B  | 27.34%        |
| 2024-09-30 | $48.93B  | 29.15%        |
| 2024-06-30 | $49.57B  | 29.66%        |

| Quarter    | Equity    | ROE     |
| :--------- | :-------- | :------ |
| 2025-06-30 | $146.42B | 1.70%   |
| 2025-03-31 | $149.24B | 2.35%   |
| 2024-12-31 | $152.32B | 2.13%   |
| 2024-09-30 | $156.20B | 2.87%   |
| 2024-06-30 | $159.23B | 2.78%   |

**Analysis:**

*   Revenue is decreasing over the recent quarters.
*   Profit margins have been relatively stable but show a slight decrease.
*   Equity is decreasing, and the Return on Equity (ROE) has also declined, indicating less efficient use of shareholder equity.

**7. Overall Summary**

*   **Underperformance:** CVX has significantly underperformed the S&P 500 recently, and its relative divergence is at the lower end of its historical range.
*   **Technicals:** The stock is in a short-term downtrend, but a recent bounce and positive change in relative divergence suggest a potential short-term recovery.
*   **Analysts:** Analyst consensus is generally positive, with a "Buy" rating and a potential upside based on target prices.
*   **News:** Recent news is mixed, with some positive developments (UBS reaffirming "Buy," potential benefits from Gulf oil growth) but also some concerns (Raymond James lowering price target).
*   **Earnings & Financials:** Recent earnings and financial data show a concerning downward trend in revenue, EPS, equity, and ROE.

**Conclusion:**

Chevron presents a mixed picture. While analysts are generally positive and some news suggests potential long-term growth, the recent underperformance relative to the S&P 500 and the declining earnings and financial metrics are causes for concern. The high expected return should be viewed cautiously.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted.
*   **If already holding CVX:** Consider holding, but monitor the situation closely, especially the next earnings report. The positive analyst sentiment and potential for a short-term recovery could justify holding.
*   **If considering buying CVX:**  Conduct further research, focusing on the reasons for the recent decline in earnings and revenue. Consider a small, initial position and dollar-cost averaging to mitigate risk. The MRI indicator also suggests this is not the best time to invest heavily in this stock

**Disclaimer:** This analysis is based on the provided data and should not be considered financial advice. Consult with a qualified financial advisor before making any investment decisions.
